• it
  • en

The big pharmaceutical companies are targeting Italy: a market that is worth 4.3 billion dollars

De Matthaeis, Labozeta: "Safety, sustainability and quality are the trump cards"

ROME, December 2, 2016 – By now the figures are speaking clearly: the multinationals of the pharmaceutical sector are increasingly turning towards Italy, so much so that 10% of pharmaceutical raw materials are now produced in and exported from this country.

This is a market with a turnover that amounts to $ 4.3 billion dollars in Italy alone, as recently revealed not only by Aschimfarma and the Italian Pharmacological Medicines Agency (AIFA), but also by the most important pharmaceutical companies, united under the name of Big Pharma, which are more and more interested in Italian manufacturing. This is not for the reasons of economic convenience that many Asiatic countries can offer. Instead it is due to the technical expertise, safety, quality, purity, timing and packaging: elements that have always distinguished made in Italy products in this very delicate sector which currently exports 85% of the active pharmaceutical ingredients made in the country, as revealed by a recent report based on a study conducted by the University of Turin.

It would definitely be worth establishing a virtuous circle of excellence, within which particular importance is attributed to the design and realization of scientific laboratories that are designed to meet the multiple needs of scientific research. "We are speaking of places that absolutely must represent the values of safety, sustainability and quality" points out Giancarlo De Matthaeis, the president of Labozeta Spa, a company that has been the leader of the field for the design and manufacture of scientific laboratories since 1983. "The know-how that Italy has achieved in this field, thanks to a strict compliance with the relevant regulations, while paying particular attention to the needs of those who live and work in chemical and pharmaceutical laboratories on a daily basis, as well as the resulting improvements in design and sustainability, have all undoubtedly encouraged a further increase in quality standards that have now reached truly excellent levels".

"Of course much still remains to be done in this sector, especially in terms of projects that are capable of creating a synergy between the various kinds of excellence and the potentialities that our country offers, according to the demands of a more circular and therefore more sustainable economy. Certainly – De Matthaeis concludes – we are heading towards the so-called 4.0 industry, which will inevitably open up some new scenarios for the production and manufacture of goods and services and will introduce a new kind of vital energy for innovation, development and above all a greater degree of vertical integration".